AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
COLLIS STEVEN H | Chairman, President & CEO | Mar 14 | Option Exercise | 77.53 | 10,499 | 813,987 | 268,466 | Mar 15 04:05 PM | COLLIS STEVEN H | Chairman, President & CEO | Mar 14 | Sale | 150.00 | 10,499 | 1,574,850 | 257,967 | Mar 15 04:05 PM | Clark Gina | Executive Vice President | Mar 01 | Sale | 156.22 | 1,924 | 300,565 | 26,733 | Mar 03 04:08 PM | COLLIS STEVEN H | Chairman, President & CEO | Feb 14 | Option Exercise | 77.53 | 10,499 | 813,987 | 268,466 | Feb 16 04:06 PM | COLLIS STEVEN H | Chairman, President & CEO | Feb 14 | Sale | 159.28 | 10,499 | 1,672,281 | 257,967 | Feb 16 04:06 PM | Krikorian Lazarus | SVP & Chief Accounting Officer | Feb 07 | Sale | 155.82 | 5,711 | 889,888 | 18,732 | Feb 09 04:06 PM | COLLIS STEVEN H | Chairman, President & CEO | Jan 17 | Option Exercise | 77.53 | 10,499 | 813,987 | 268,466 | Jan 19 04:06 PM | COLLIS STEVEN H | Chairman, President & CEO | Jan 17 | Sale | 164.28 | 10,499 | 1,724,776 | 257,967 | Jan 19 04:06 PM | Donato Leslie E | EVP & Chief Strategy Officer | Dec 22 | Sale | 170.00 | 930 | 158,100 | 6,054 | Dec 23 04:04 PM | Krikorian Lazarus | SVP & Chief Accounting Officer | Dec 21 | Option Exercise | 89.58 | 2,218 | 198,688 | 22,225 | Dec 22 04:04 PM | Krikorian Lazarus | SVP & Chief Accounting Officer | Dec 21 | Sale | 169.24 | 2,218 | 375,374 | 20,007 | Dec 22 04:04 PM | Battaglia Silvana | Executive Vice President | Dec 16 | Option Exercise | 86.09 | 9,031 | 777,479 | 19,815 | Dec 20 04:02 PM | Battaglia Silvana | Executive Vice President | Dec 16 | Sale | 167.00 | 9,852 | 1,645,284 | 10,784 | Dec 20 04:02 PM | COLLIS STEVEN H | Chairman, President & CEO | Dec 13 | Option Exercise | 75.61 | 45,920 | 3,472,011 | 303,887 | Dec 14 04:52 PM | COLLIS STEVEN H | Chairman, President & CEO | Dec 13 | Sale | 165.62 | 45,920 | 7,605,365 | 257,967 | Dec 14 04:52 PM | COLLIS STEVEN H | Chairman, President & CEO | Dec 12 | Sale | 166.01 | 33,000 | 5,478,330 | 257,967 | Dec 14 04:52 PM | Clark Gina | Executive Vice President | Dec 12 | Sale | 166.30 | 392 | 65,190 | 28,657 | Dec 14 05:33 PM | Donato Leslie E | EVP & Chief Strategy Officer | Dec 09 | Sale | 166.12 | 3,014 | 500,686 | 6,984 | Dec 12 04:20 PM | Walgreens Boots Alliance, Inc. | 10% Owner | Dec 08 | Sale | 165.08 | 5,961,534 | 984,130,033 | 33,659,180 | Dec 12 05:26 PM | Walgreens Boots Alliance, Inc. | 10% Owner | Nov 07 | Sale | 154.60 | 13,234,153 | 2,046,000,054 | 39,629,714 | Nov 09 08:00 AM | Mauch Robert P. | Executive Vice President & COO | Nov 04 | Sale | 160.00 | 21,802 | 3,488,320 | 20,197 | Nov 04 06:19 PM | COLLIS STEVEN H | Chairman, President & CEO | Oct 11 | Option Exercise | 75.61 | 11,480 | 868,003 | 216,658 | Oct 12 04:31 PM | COLLIS STEVEN H | Chairman, President & CEO | Oct 11 | Sale | 141.72 | 11,480 | 1,626,946 | 205,178 | Oct 12 04:31 PM | COLLIS STEVEN H | Chairman, President & CEO | Sep 13 | Option Exercise | 75.61 | 11,480 | 868,003 | 216,658 | Sep 15 04:24 PM | COLLIS STEVEN H | Chairman, President & CEO | Sep 13 | Sale | 142.40 | 11,480 | 1,634,752 | 205,178 | Sep 15 04:24 PM | Donato Leslie E | EVP & Chief Strategy Officer | Sep 02 | Option Exercise | 0.00 | 2,975 | 0 | 4,784 | Sep 06 04:48 PM | Clark Gina | Executive Vice President | Aug 30 | Sale | 146.80 | 288 | 42,278 | 15,526 | Sep 01 04:05 PM | COLLIS STEVEN H | Chairman, President & CEO | Aug 09 | Option Exercise | 75.61 | 11,480 | 868,003 | 216,658 | Aug 11 04:14 PM | COLLIS STEVEN H | Chairman, President & CEO | Aug 09 | Sale | 144.25 | 11,480 | 1,655,990 | 205,178 | Aug 11 04:14 PM | COLLIS STEVEN H | Chairman, President & CEO | Jul 12 | Option Exercise | 75.61 | 11,480 | 868,003 | 216,658 | Jul 14 04:04 PM | COLLIS STEVEN H | Chairman, President & CEO | Jul 12 | Sale | 142.35 | 11,480 | 1,634,178 | 205,178 | Jul 14 04:04 PM | Donato Leslie E | EVP & Chief Strategy Officer | Jul 01 | Option Exercise | 0.00 | 1,431 | 0 | 2,342 | Jul 22 04:05 PM | COLLIS STEVEN H | Chairman, President & CEO | Jun 14 | Option Exercise | 75.61 | 11,480 | 868,003 | 216,658 | Jun 16 04:20 PM | COLLIS STEVEN H | Chairman, President & CEO | Jun 14 | Sale | 141.22 | 11,480 | 1,621,206 | 205,178 | Jun 16 04:20 PM | Walgreens Boots Alliance, Inc. | 10% Owner | May 11 | Sale | 150.00 | 6,000,000 | 900,000,000 | 52,854,867 | May 13 04:59 PM | Krikorian Lazarus | SVP & Chief Accounting Officer | May 11 | Sale | 160.00 | 4,895 | 783,200 | 14,079 | May 13 04:04 PM | COLLIS STEVEN H | Chairman, President & CEO | May 10 | Option Exercise | 75.61 | 11,480 | 868,003 | 216,658 | May 12 04:44 PM | Krikorian Lazarus | SVP & Chief Accounting Officer | May 10 | Option Exercise | 89.58 | 6,654 | 596,065 | 25,733 | May 12 04:40 PM | COLLIS STEVEN H | Chairman, President & CEO | May 10 | Sale | 159.47 | 11,480 | 1,830,716 | 205,178 | May 12 04:44 PM | Krikorian Lazarus | SVP & Chief Accounting Officer | May 10 | Sale | 158.63 | 6,759 | 1,072,191 | 18,974 | May 12 04:40 PM | COLLIS STEVEN H | Chairman, President & CEO | Apr 12 | Option Exercise | 75.61 | 11,480 | 868,003 | 216,658 | Apr 13 04:22 PM | COLLIS STEVEN H | Chairman, President & CEO | Apr 12 | Sale | 162.11 | 11,480 | 1,861,023 | 205,178 | Apr 13 04:22 PM | Clark Gina | Executive Vice President | Mar 28 | Option Exercise | 75.61 | 29,520 | 2,232,007 | 59,518 | Mar 30 04:00 PM | Clark Gina | Executive Vice President | Mar 28 | Sale | 153.71 | 43,704 | 6,717,742 | 15,814 | Mar 30 04:00 PM |
|